Tardive dyskinesia prevalence rates during a ten-year follow-up. 1995

C H Miller, and I Simioni, and H Oberbauer, and J Schwitzer, and C Barnas, and F Kulhanek, and K E Boissel, and U Meise, and H Hinterhuber, and W W Fleischhacker
Department of Biological Psychiatry, Psychiatric Hospital, University of Innsbruck, Austria.

We followed up patients in the State Psychiatric Hospital Mauer-Ohling, Mauer-Ohling, Austria, who had been examined in 1982 to determine the prevalence of tardive dyskinesia (TD). Of the 861 patients examined in 1982, 270 were still in hospital 10 years later. Only these patients were included in our study. The SKAUB (Skala für abnorme unwillkürliche Bewegungen, i.e., The German version of the Abnormal Involuntary Movement Scale) was used to quantify the occurrence of TD. The prevalence rate of TD was 3.7% in 1982 and 12.7% in 1992. The 1992 prevalence rate in patients who had not shown TD symptoms in 1982 was 11.4%. The major risk factor for TD was advanced age.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004409 Dyskinesia, Drug-Induced Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199) Dyskinesia, Medication-Induced,Medication-Induced Dyskinesia,Drug-Induced Dyskinesia,Drug-Induced Dyskinesias,Dyskinesia, Drug Induced,Dyskinesia, Medication Induced,Dyskinesias, Drug-Induced,Dyskinesias, Medication-Induced,Medication Induced Dyskinesia,Medication-Induced Dyskinesias
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006778 Hospitals, Psychiatric Special hospitals which provide care to the mentally ill patient. Mental Hospitals,Hospitals, Mental,Mental Institutions,Psychiatric Hospitals,Hospital, Mental,Hospital, Psychiatric,Institution, Mental,Institutions, Mental,Mental Hospital,Mental Institution,Psychiatric Hospital
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

C H Miller, and I Simioni, and H Oberbauer, and J Schwitzer, and C Barnas, and F Kulhanek, and K E Boissel, and U Meise, and H Hinterhuber, and W W Fleischhacker
October 1989, Canadian journal of psychiatry. Revue canadienne de psychiatrie,
C H Miller, and I Simioni, and H Oberbauer, and J Schwitzer, and C Barnas, and F Kulhanek, and K E Boissel, and U Meise, and H Hinterhuber, and W W Fleischhacker
November 1984, Psychosomatics,
C H Miller, and I Simioni, and H Oberbauer, and J Schwitzer, and C Barnas, and F Kulhanek, and K E Boissel, and U Meise, and H Hinterhuber, and W W Fleischhacker
February 1983, Psychological medicine,
C H Miller, and I Simioni, and H Oberbauer, and J Schwitzer, and C Barnas, and F Kulhanek, and K E Boissel, and U Meise, and H Hinterhuber, and W W Fleischhacker
October 1983, The British journal of psychiatry : the journal of mental science,
C H Miller, and I Simioni, and H Oberbauer, and J Schwitzer, and C Barnas, and F Kulhanek, and K E Boissel, and U Meise, and H Hinterhuber, and W W Fleischhacker
October 1992, Acta psychiatrica Scandinavica,
C H Miller, and I Simioni, and H Oberbauer, and J Schwitzer, and C Barnas, and F Kulhanek, and K E Boissel, and U Meise, and H Hinterhuber, and W W Fleischhacker
January 1986, Psychopharmacology bulletin,
C H Miller, and I Simioni, and H Oberbauer, and J Schwitzer, and C Barnas, and F Kulhanek, and K E Boissel, and U Meise, and H Hinterhuber, and W W Fleischhacker
January 1985, Advances in biochemical psychopharmacology,
C H Miller, and I Simioni, and H Oberbauer, and J Schwitzer, and C Barnas, and F Kulhanek, and K E Boissel, and U Meise, and H Hinterhuber, and W W Fleischhacker
June 1994, The American journal of psychiatry,
C H Miller, and I Simioni, and H Oberbauer, and J Schwitzer, and C Barnas, and F Kulhanek, and K E Boissel, and U Meise, and H Hinterhuber, and W W Fleischhacker
December 1977, Journal of the American Geriatrics Society,
C H Miller, and I Simioni, and H Oberbauer, and J Schwitzer, and C Barnas, and F Kulhanek, and K E Boissel, and U Meise, and H Hinterhuber, and W W Fleischhacker
February 1990, Acta psychiatrica Scandinavica,
Copied contents to your clipboard!